Zotefoams PLC Director/PDMR Shareholding (1326B)
June 14 2016 - 5:31AM
UK Regulatory
TIDMZTF
RNS Number : 1326B
Zotefoams PLC
14 June 2016
14 June 2016
Zotefoams plc
(the 'Company')
Directors' Share Dealings
The Company was notified on 13 June 2016 that on the same day
the following Directors became beneficially interested in the
number of ordinary shares of 5 pence in the Company set out against
their names in the table below under the Zotefoams Share Incentive
Plan (the 'SIP'). The shares were purchased on their behalf by the
SIP Trustee (Yorkshire Building Society) at a price of GBP2.9405
per share.
The SIP is an all-employee trust arrangement approved by HM
Revenue and Customs, under which employees are able to buy ordinary
shares in the Company, using deductions from salary in each monthly
pay period, and receive allocations of matching free ordinary
shares ('matching shares'). Dividends received on the shares held
in the SIP are used to buy further ordinary shares ('dividend
shares') in the Company.
The table below sets out the number of shares purchased and the
number of matching shares that were allocated for no
consideration.
Director Number of No. of matching
shares purchased shares allocated
-------------- ------------------ ------------------
D B Stirling 51 13
-------------- ------------------ ------------------
G C McGrath 51 13
-------------- ------------------ ------------------
Following the above-mentioned transactions, Mr Stirling and Mr
McGrath are beneficially interested in the following number of
shares:
Director Number of Percentage
shares(1) of issued
Share Capital
-------------- ----------- ---------------
D B Stirling 379,446 0.85
-------------- ----------- ---------------
G C McGrath 154 0.00
-------------- ----------- ---------------
(1) Includes partnership shares, dividend shares and vested
matching shares.
This disclosure has been made for the purposes of DTR 3.1.4.
Enquiries:
James Kindell
Company Secretary
Zotefoams plc
020 8664 1600
About Zotefoams plc:
Zotefoams plc (LSE - ZTF) is a world leader in cellular material
technology. Using a unique manufacturing process with
environmentally friendly nitrogen expansion, Zotefoams produces
lightweight foams under the family brand names AZOTE(R) and
ZOTEK(R) in Croydon, UK and Kentucky, USA for diverse markets
worldwide through its global sales force. Zotefoams also owns and
licenses patented MuCell(R) microcellular foam technology from a
base in Massachusetts, USA to customers worldwide and sells
T-FIT(R) advanced insulation systems made from its patented
ZOTEK(R) fluoropolymer foams.
AZOTE(R), T-FIT(R) and ZOTEK(R) are registered trademarks of
Zotefoams plc. MuCell(R) is a registered trademark of Trexel Inc,
licensed exclusively to MuCell Extrusion LLC for use in
microcellular foaming of extrusion products.
www.zotefoams.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEANKLFDEKEEF
(END) Dow Jones Newswires
June 14, 2016 05:31 ET (09:31 GMT)
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Sep 2023 to Sep 2024